Synthesis, biological evaluation and docking studies of 1,2,4-oxadiazole linked 5-fluorouracil derivatives as anticancer agents. 2021

Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
Sreenidhi Institute of Science and Technology (Autonomous), Yamnampet, Ghatkesar, Hyderabad, Telangana, India.

BACKGROUND 1,2,4-oxadiazole derivatives exhibited significant anti-cancer activity when they were evaluated, against human cancer cell lines. They also showed anti-inflammatory, analgesic, diabetic, immunosuppressive, α,β3-receptor antagonist, antimicrobial, anti-helminthic, histamine-H3 and antiparasitic properties. A pyrimidine analog, 5 fluoro-uracil is a chemotherapeutic drug used for treating multiple solid malignant tumors. But its application is limited, as it has side effects like low bioavailability and high toxicity. Molecular docking is an exemplary tool, helps in identifying target and designing a drug containing high bio-availability and minimum toxicity. RESULTS A set of 1,2,4-oxadiazole linked 5-fluoruracil derivatives (7a-j) were synthesized and their structures were confirmed by 1HNMR, 13CNMR and Mass spectral analysis. Further, these compounds were investigated for their anticancer activity towards a panel of four human cancer cell lines such as (MCF-7, MDA MB-231), lung cancer (A549) and prostate cancer (DU-145) by using MTT method. Among them, compounds 7a, 7b, 7c, 7d and 7i demonstrated more promising anticancer activity than standard. CONCLUSIONS Synthesized derivatives (7a-j) of 1,2,4-oxadiazole linked 5-fluorouracil and investigated for their anticancer activity towards a panel of four human cancer cell lines.

UI MeSH Term Description Entries

Related Publications

Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
October 2020, Bioorganic & medicinal chemistry letters,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
November 2011, Bioorganic & medicinal chemistry,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
May 2012, Bioorganic & medicinal chemistry,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
December 2019, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
September 2020, Bioorganic & medicinal chemistry letters,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
February 2012, Bioorganic & medicinal chemistry,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
March 2024, ACS omega,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
February 2018, Bioorganic chemistry,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
December 2015, Bioorganic chemistry,
Ravi Kumar Bommera, and Shashikala Kethireddy, and Rajeshwar Reddy Govindapur, and Laxminarayana Eppakayala
January 2018, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!